US EditionWhat's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday? - Sarepta Therapeutics (NASDAQ:SRPT), Capricor Therapeutics (NASDAQ:CAPR)
2 Articles
2 Articles
What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday? - Sarepta Therapeutics (NASDAQ:SRPT), Capricor Therapeutics (NASDAQ:CAPR)
In May, FDA Commissioner Marty Makary named Vinay Prasad the next director of the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER). Within three months, Prasad resigned. “Dr. Prasad did not want to be a distraction to the great work of the FDA in the Trump administration and has decided to return to California and spend more time with his family,” a spokesperson for the US Department of Health and Hum…
A 16-year-old dies after the gene therapy Elevidys. An 8-year-old succumbs to the complications of a similar treatment in Brazil. The FDA reacts with an alleged emergency brake – and gives the green light a few weeks later for the resumption of the delivery. The result: The share of the US biotech company Sarepta Therapeutics is fasting up again after months of price losses. It has to be melted on the tongue: Four deaths in connection with vario…
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
